Mutations in NOD2, encoding an intracellular bacteria-sensing protein, have been associated recently with Crohn disease. Two studies in mice investigate how these mutations may affect innate immunity to microbes in the intestine and progression of disease.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Down-Regulation of Human Enteric Antimicrobial Peptides by NOD2 during Differentiation of the Paneth Cell Lineage
Scientific Reports Open Access 11 February 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Katherine Ris
References
Bonen, D.K. et al. Gastroenterology 124, 140–146 (2003).
Hugot, J.P. et al. Nature 411, 599–603 (2001).
Ogura, Y. et al. Nature 411, 603–6 (2001).
Inohara, N., Chamaillard, M., McDonald, C. & Nunez, G. Annu. Rev. Biochem. 74, 355–383 (2005).
Maeda, S. et al. Science 307, 734–738 (2005).
Bouma, G. & Strober, W. Nat. Rev. Immunol. 3, 521–533 (2003).
Hampe, J. et al. Lancet 357, 1925–1928 (2001).
Ogura, Y. et al. Gut 52, 1591–1597 (2003).
Lala, S. et al. Gastroenterology 125, 47–57 (2003).
Watanabe, T., Kitani, A., Murray, P.J. & Strober, W. Nat. Immunol. 5, 800–808 (2004).
Strober, W., Fuss, I.J. & Blumberg, R.S. Annu. Rev. Immunol. 20, 495–549 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kelsall, B. Getting to the guts of NOD2. Nat Med 11, 383–384 (2005). https://doi.org/10.1038/nm0405-383
Issue Date:
DOI: https://doi.org/10.1038/nm0405-383
